Emmanuel Andrès, Nathalie Jeandidier, Laurent Meyer, Thibault Bahougne, Abrar-Ahmad Zulfiqar, Samy Talha, Noel Lorenzo Villalba, Mohamed Hajjam and Amir Hajjam El Hassani
In recent years, several technological innovations such as non-invasive glucose sensors, intelligent insulin pumps, artificial pancreas, telemedicine, and artificial intelligence have become part of the daily lives of diabetic patients. A review of the literature dedicated to these technologies supports the efficacy of them in diabetic patients. Mainly, these technologies have shown a beneficial effect on diabetes management with an improvement of blood glucose control, with a significant reduction in HbA1c, patient ownership of the disease, patient adherence to therapeutic and hygiene-dietary measures, the management of co-morbidities (hypertension, weight, dyslipidemia), and at least, good patient receptivity and accountability. Especially, the emergence of these technologies in the daily lives of diabetic patients has led to an improvement in the quality of life for patients. To date, the magnitude of their effects remains debatable, especially with the variation in patients’ characteristics, sample selection and approach for treatment of control groups.